Modesto, CANCT06850922Now EnrollingIRB Ready

Diabetic Macular Edema Clinical Trial in Modesto, CA

Access cutting-edge diabetic macular edema treatment through this clinical trial at a research site in Modesto. Study-provided care at no cost to qualified participants.

Sponsored by Genentech, Inc.

Quick Self-Assessment

See if you qualify for this Modesto location

Preparing your pre-screening questions...

Expert Care in Modesto

Access diabetic macular edema specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic macular edema treatment provided free

Apply for This Modesto Location

Check if you qualify for this diabetic macular edema clinical trial in Modesto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Modesto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Modesto site if eligible
  4. 4Begin participation

About This Diabetic Macular Edema Study in Modesto

This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1-4) and Phase II (Part 5). Phase I investigated the safety of RO7446603 following a single and multiple intravitreal (IVT) doses as monotherapy or co-administered with IVT aflibercept or IVT faricimab (in separate injections). Phase II will investigate the safety, tolerability, pharmacokinetics (PK)

Sponsor: Genentech, Inc.

Who Can Participate

Inclusion Criteria

Documented diagnosis of diabetes mellitus (DM) (Type 1 or Type 2) with glycated hemoglobin (HbA1c) \< 12%
Macular thickening secondary to DME involving the center of the fovea \> 325 microns
Decreased VA attributable primarily to DME between 25 and 73 ETDRS letters

Exclusion Criteria

Currently untreated DM or previously untreated participants who initiated oral anti-diabetic medication or insulin within 90 days prior to Day 1
Uncontrolled blood pressure (BP)
Pregnancy or breastfeeding, or intention to become pregnant during the study
For Parts 1-4: IVT anti-VEGF treatment within 90 days prior to Day 1; For Part 5: IVT anti-VEGF treatment within 120 days prior to Day 1 or IVT anti-VEGF treatment prior to Day 1 for treatment naïve participants
Treatment with SUSVIMOTM (ranibizumab injection) prior to Day 1
Any IVT or periocular (sub-tenons) corticosteroid treatment within 6 months prior to Day 1
Any current or history of ocular disease other th

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Modesto?

Yes, this clinical trial (NCT06850922) has an active research site in Modesto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Macular Edema Treatment Options in Modesto, CA

If you're searching for diabetic macular edema treatment options in Modesto, CA, this clinical trial (NCT06850922) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Modesto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic macular edema clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Modesto, CA

See all essential tremor clinical trials recruiting in Modesto — not just this study.

Browse Essential Tremor Trials in Modesto

Ready to Join in Modesto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Modesto, CA